Any current/future capex/capital investment/strategic investment?

Apollo Hospitals plans to operationalize 4 new hospitals adding 1,500 beds in key markets: Gurgaon, Kolkata, Hyderabad, and Pune within the next 5 quarters. There is a brownfield expansion in Mysore with 140 beds. Investments are being made in expanding specialty manpower and diagnostic capacity. Apollo HealthCo is investing in omni-channel customer acquisition, digital therapeutics, insurance, and app monetization, aiming for breakeven in 6-7 quarters. The company is experimenting with faster medicine delivery models for acute/emergency customers. Cost optimization and calibrated growth inves

Future growth expectations in sales/revenue/volumes?

Healthcare Services revenue grew 15% YoY; expected continued double-digit volume growth driven by quality and insurance coverage expansion. Anticipated ARPOB growth improvement over next quarters due to better case mix and increased surgical volume. Hospitals to operationalize 4 new facilities (Gurgaon, Kolkata, Hyderabad, Pune) adding 1,500 beds over next 5 quarters, aiding volume growth. Pharmacy business expects 50% growth over last year, with recovery in Q2 and Q3 post-operating model changes. Apollo 24/7 platform GMV growing at 9%; growth expected to accelerate in next two quarters, targe

Future growth expectations in earnings/operating earnings/profits/EPS?

Apollo Hospitals is optimistic about its growth trajectory across all business verticals for FY25 and beyond (page 16). Healthcare Services revenue grew 15% YoY; occupancy increased by 600 bps, expected to sustain or improve (pages 2, 9). EBITDA margins in Healthcare Services expected to expand by 100 bps over next 3-4 quarters due to volume growth, better case mix, and cost optimization (pages 2, 7). Apollo 24/7 digital segment aims for breakeven within 6-7 quarters, with margin improvement expected as pharmacy mix improves and new verticals contribute (pages 13). Pharmacy segment discounts r

Apollo Hospitals Enterprise LtdQ1 FY25Healthcare Services

Apollo Hospitals Enterprise Ltd Q1 FY25 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹8,134P/E: 60.8Market Cap: ₹1.3L CrSector: Healthcare Services

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3

Healthcare Services revenue grew 15% YoY; expected continued double-digit volume growth driven by quality and insurance coverage expansion.
Anticipated ARPOB growth improvement over next quarters due to better case mix and increased surgical volume.
Hospitals to operationalize 4 new facilities (Gurgaon, Kolkata, Hyderabad, Pune) adding 1,500 beds over next 5 quarters, aiding volume growth.
Pharmacy business expects 50% growth over last year, with recovery in Q2 and Q3 post-operating model changes.
Apollo 24/7 platform GMV growing at 9%; growth expected to accelerate in next two quarters, targeting break-even in 6-7 quarters.
Offline pharmacy store additions projected at 500–550 stores annually, boosting distribution revenue.
Digital and corporate channels, insurance, and digital therapeutics seen as key drivers for future growth and margin expansion.
Focus remains on volume-driven growth over ARPOB for sustainable profitability.

Margin guidance

Category 3

Apollo Hospitals is optimistic about its growth trajectory across all business verticals for FY25 and beyond (page 16).
Healthcare Services revenue grew 15% YoY; occupancy increased by 600 bps, expected to sustain or improve (pages 2, 9).
EBITDA margins in Healthcare Services expected to expand by 100 bps over next 3-4 quarters due to volume growth, better case mix, and cost optimization (pages 2, 7).
Apollo 24/7 digital segment aims for breakeven within 6-7 quarters, with margin improvement expected as pharmacy mix improves and new verticals contribute (pages 13).
Pharmacy segment discounts reduced; growth expected to normalize with 50% annual GMV growth target maintained (pages 12, 6).
Hospital EBITDA margins are expected to be 100-150 bps lower in FY26 due to new units but overall improving profitability due to volume and operational efficiencies (page 10).
Consolidated PAT grew 83% YoY; management expects further steady improvements through strategic initiatives (page 3).

See what Apollo Hospitals Enterprise Ltd management said on margin guidance — free account, 30 seconds.

Fundraise plans

The transcript from the Q1 FY25 earnings call of Apollo Hospitals Limited (Page 16 and other pages) does not mention any current or future plans for fundraising through debt or equity. Key points related to financial strategies include: - Focus on profitability enhancement and operational excellence. - Maintaining guidance on growth and EBITDA margins without revision. - Investment in new initiatives and expansions primarily funded through existing operations. - No explicit mention of raising funds via debt or equity in the near term. Thus, based on the call transcript, there is no disclosed plan for new fundraising through debt or equity at this time.

Order book

The transcript provided from the AHEL Q1 FY25 Earnings Call does not contain any specific information regarding the current or expected order book or pending orders for Apollo Hospitals or its subsidiaries. The discussion primarily revolves around business performance metrics like occupancy, revenue growth, pharmacy discounting, customer acquisition costs, and expansion plans, but it does not mention order book status or pending order details.

See what Apollo Hospitals Enterprise Ltd management said on order book — free account, 30 seconds.

Capex plans

Yes

Apollo Hospitals plans to operationalize 4 new hospitals adding 1,500 beds in key markets: Gurgaon, Kolkata, Hyderabad, and Pune within the next 5 quarters.
There is a brownfield expansion in Mysore with 140 beds.
Investments are being made in expanding specialty manpower and diagnostic capacity.
Apollo HealthCo is investing in omni-channel customer acquisition, digital therapeutics, insurance, and app monetization, aiming for breakeven in 6-7 quarters.
The company is experimenting with faster medicine delivery models for acute/emergency customers.
Cost optimization and calibrated growth investments are ongoing to support expansion while managing operational expenses.

Track Apollo Hospitals Enterprise Ltd — get its next earnings analysis in your feed

How does Apollo Hospitals Enterprise Ltd rank vs peers in Healthcare Services?

Pro feature

ThisApollo Hospitals Enterprise Ltd

Rev 3Mar 3

See where Apollo Hospitals Enterprise Ltd sits in Healthcare ServicesSee which companies these are, and every other name in the sector.Open rankings

How does Apollo Hospitals Enterprise Ltd rank in Healthcare Services?

Compare Apollo Hospitals Enterprise Ltd against every Healthcare Services company (Q1 FY25) on revenue, margins and earnings-call signals.

View Healthcare Services leaderboard →

What Apollo Hospitals Enterprise Ltd's management said in earlier quarters

Others in Healthcare Services this season

KMC Speciality Hospitals (India) Ltd (Q4 FY26)
Q4 FY’26 Revenue from Operations: INR 82.3 Cr, up 35.0% YoY from INR 60.9 Cr in Q4 FY’25 (Page 20) . Key concall takeaways from KMC Speciality Hospitals…
KMC Speciality Hospitals (India) Ltd (Q1 FY27)
Q1 FY'27 Revenue from operations: INR 91.8 Cr, up 38% YoY from INR 66.6 Cr in Q1 FY'26. Key concall takeaways from KMC Speciality Hospitals (India) Ltd's Q1…
Suven Life Sciences Ltd (Q1 FY22)
The provided pages of the Suven Life Sciences investor presentation do not contain any specific revenue, sales, or volume figures for any quarter. Key concall…
Vimta Labs Ltd (Q3 FY25)
Q3 FY25 Revenue from Operations: ₹899 Mn . Key concall takeaways from Vimta Labs Ltd's Q3 FY25 earnings call — and how it ranks against sector peers.

Compare:vs Max Healthcare vs Manipal Health vs Aster DM Quality

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Apollo Hospitals Enterprise Ltd Q1 FY25 Earnings Call Analysis

Revenue guidance

Fundraise plans

Capex plans

How does Apollo Hospitals Enterprise Ltd rank in Healthcare Services?

Continue your research

What Apollo Hospitals Enterprise Ltd's management said in earlier quarters

Others in Healthcare Services this season